SIREN : 422397919
PHAR-MAT is a French company founded 27 years ago, specialized in the sector Commerce de gros (commerce interentreprises) d'autres biens domestiques . Based in PARIS (75020), this company of category PME shows in 2017 a revenue of 10 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Kennzahl | 2018 | 2017 | 2016 |
|---|---|---|---|
| Umsatz | N/C | 9 500 € | 10 000 € |
| Nettoergebnis | 4 518 € | 4 378 € | 5 619 € |
| EBITDA | -73 € | 4 378 € | 5 619 € |
| Nettomarge | N/C | 46.1% | 56.2% |
In 2018, PHAR-MAT generates positive net income of 5 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2018: 6 k€ -> 5 k€.
-73 €
4 518 €
4 518 €
The debt ratio (= Financial debt / Equity x 100) stands at 76%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 11%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 2.9 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.
76.14%
11.109%
2.912
In 2018, the debt ratio of PHAR-MAT (76.14) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2018, the financial autonomy of PHAR-MAT (11.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2018, the repayment capacity of PHAR-MAT (2.91) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 134.59. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
134.588
0.0
In 2018, the liquidity ratio of PHAR-MAT (134.59) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2018, the interest coverage of PHAR-MAT (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Indicative estimate only : the number of comparable transactions in this sector is limited (28 transactions). This range of 9 467€ to 31 760€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 28 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare PHAR-MAT with other companies in the same sector:
The revenue of PHAR-MAT in 2017 is 10 k€.
Yes, PHAR-MAT generated a net profit of 5 k€ in 2018.
The headquarters of PHAR-MAT is located in PARIS (75020), in the department Paris.
The tax return of PHAR-MAT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
PHAR-MAT operates in the sector Commerce de gros (commerce interentreprises) d'autres biens domestiques (NAF code 46.49Z). See the 'Sector positioning' section above to compare the company with its competitors.